KIMBERLY SLATTON: Open Payments
NPI 1780180927 · BLUE RIDGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,178 in 43 payments from 20 companies in 2025. Trend: 2023 $129 · 2024 $2,331 · 2025 $1,178
Food & beverage: $1,178
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $219 |
| Sumitomo Pharma America, Inc. | 6 | $165 |
| Ferring Pharmaceuticals Inc. | 5 | $111 |
| UROGEN PHARMA, INC. | 3 | $86 |
| Boston Scientific Corporation | 1 | $72 |
| Verity Pharmaceuticals Inc. | 4 | $70 |
| Myriad Genetic Laboratories, Inc. | 3 | $67 |
| Janssen Biotech, Inc. | 2 | $61 |
| Linvatec Corporation | 1 | $46 |
| Teleflex LLC | 2 | $39 |
Products named: Nubeqa, ORGOVYX, ADSTILADRIN, Axonics, PROLARIS, ZUSDURI, ERLEADA, Trelstar.
Industry payments across GA — which companies pay providers there.
